Higher-Than-Conventional Radiation Doses in Localized Prostate Cancer Treatment: A Meta-analysis of Randomized, Controlled Trials

International Journal of Radiation Oncology Biology Physics

Volumn 74, Issue 5, 2009, Pages 1405-1418

  Viani, Gustavo Arruda ^a   Stefano, Eduardo Jose ^a   Afonso, Sergio Luis ^a  

^a Marilia Medical School   (Brazil)

Author keywords

Biochemical control; High dose radiotherapy; Meta analysis; Mortality; Prostate cancer

Indexed keywords

BIOCHEMICAL CONTROL; HIGH-DOSE RADIOTHERAPY; META-ANALYSIS; MORTALITY; PROSTATE CANCER;

RADIOTHERAPY; REGRESSION ANALYSIS; RISK ANALYSIS;

QUALITY ASSURANCE;

ARTICLE; CANCER MORTALITY; CANCER RADIOTHERAPY; CLINICAL TRIAL; COMPUTER ASSISTED RADIOTHERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CONVENTIONAL DOSE RADIOTHERAPY; GASTROINTESTINAL TOXICITY; HIGH DOSE RADIOTHERAPY; HUMAN; MALE; META ANALYSIS; PHOTON THERAPY; PRIORITY JOURNAL; PROSTATE CANCER; PUBLISHING; RADIATION DOSE; RANDOMIZED CONTROLLED TRIAL; SYSTEMATIC REVIEW; TREATMENT FAILURE; TREATMENT OUTCOME; UROGENITAL TRACT DISEASE;

DOSE-RESPONSE RELATIONSHIP, RADIATION; HUMANS; MALE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REGRESSION ANALYSIS; SURVIVAL RATE;

EID: 67651112123     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2008.10.091     Document Type: Article

References (32)

1. Zelefsky M.J., Leibel S.A., Gaudin P.B., et al. Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer. Int J Radiat Oncol Biol Phys 41 (1998) 491-502
2. Morris D.E., Emami B., Mauch P.M., et al. Evidence-based review of three-dimensional conformal radiotherapy for localized prostate cancer: An ASTRO outcomes initiative. Int J Radiat Oncol Biol Phys 62 (2005) 3-15
3. Andrews J., and Roach III M. Integrating hormonal therapy with external-beam radiation and brachytherapy for prostate cancer. Oncology (Williston Park) 19 (2005) 29-40
4. D'Amico A.V., Whittington R., Malkowicz S.B., et al. Pretreatment nomogram for prostate-specific antigen recurrence after radical prostatectomy or external-beam radiation therapy for clinically localized prostate cancer. J Clin Oncol 17 (1999) 168-170
5. Horwitz E.M., Vicini F.A., Ziaja E.L., et al. Assessing the variability of outcome for patients treated with localized prostate irradiation using different definitions of biochemical control. Int J Radiat Oncol Biol Phys 36 (1996) 565-574
6. Kaplan I.D., Cox R.S., and Bagshaw M.A. Prostate specific antigen after external beam radiotherapy for prostatic cancer: Followup. J Urol 149 (1993) 519-531
7. Zietman A.L., Coen J.J., Dallow K.C., et al. The treatment of prostate cancer by conventional radiation therapy: An analysis of long-term outcome. Int J Radiat Oncol Biol Phys 32 (1995) 287-299
8. Kuban D.A., Thames H.D., Levy L.B., et al. Long-term multi-institutional analysis of stage T1-T2 prostate cancer treated with radiotherapy in the PSA era. Int J Radiat Oncol Biol Phys 57 (2003) 915-927
9. Pollack A., Zagars G.K., Starkschall G., et al. Prostate cancer radiation dose response: Results of the M.D. Anderson Phase III randomized trial. Int J Radiat Oncol Biol Phys 53 (2002) 1097-1116
10. Pollack A., Hanlon A.L., Horwitz E.M., et al. Prostate cancer radiotherapy dose response: An update of the Fox Chase experience. J Urol 171 (2004) 1132-1145
11. Hanks G.E., Hanlon A.L., Pinover W.H., et al. Dose selection for prostate cancer patients based on dose comparison and dose response studies. Int J Radiat Oncol Biol Phys 46 (2000) 823-844
12. Valicenti R., Lu J., Pilepich M., et al. Survival advantage from higher-dose radiation therapy for clinically localized prostate cancer treated on the Radiation Therapy Oncology Group trials. J Clin Oncol 18 (2000) 2740-2749
13. Kupelian P.A., Mohan D.S., Lyons J., et al. Higher than standard radiation doses (>or =72 Gy) with or without androgen deprivation in the treatment of localized prostate cancer. Int J Radiat Oncol Biol Phys 46 (2000) 567-574
14. Zelefsky M.J., Fuks Z., Hunt M., et al. High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer. J Urol 166 (2001) 876-886
15. Vicini F.A., Abner A., Baglan K.L., et al. Defining a dose-response relationship with radiotherapy for prostate cancer: Is more really better?. Int J Radiat Oncol Biol Phys 51 (2001) 1200-1208
16. Schellhammer P.F. Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer: Will more prove better?. Int J Radiat Oncol Biol Phys 41 (1998) 489-490
17. In: Clarke M., and Oxman A.D. (Eds). Analysing and presenting results. Cochrane reviewers handbook, 4.1.6 (updated January 2003), section 8 (2003), Update Software, Oxford
18. Der Simonian R., and Laird N. Meta-analysis in clinical trials. Control Clin Trials 7 (1986) 177-188
19. Begg C.B., and Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 50 (1994) 1088-1101
20. Egger M., Smith G.D., Schneider M., et al. Bias in meta-analysis detected by a simple graphical test. BMJ 315 (1997) 629-634
21. Cochran W.G. The combination of estimates from different experiments. Biometrics 8 (1954) 101-129
22. Kuban D.A., Tucker S.L., Dong L., et al. Long-term results of the M.D. Anderson randomized dose-escalation trial for prostate cancer. Int J Radiat Oncol Biol Phys 70 (2008) 67-75
23. Zietman A.L., DeSilvio M.L., Slater J.D., et al. Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: A randomized controlled trial. JAMA 294 (2005) 1233-1240
24. Sathya J.R., Davis I.R., Julian J.A., et al. Randomized trial comparing iridium implant plus external-beam radiation therapy with external-beam radiation therapy alone in node-negative locally advanced cancer of the prostate. J Clin Oncol 23 (2005) 1192-1200
25. Peeters S.T., Heemsbergen W.D., Koper P.C., et al. Dose-response in radiotherapy for localized prostate cancer: Results of the Dutch multicenter randomized phase III trial comparing 68 Gy of radiotherapy with 78 Gy. J Clin Oncol 24 (2006) 1990-1999
26. Shipley W.U., Verhey L.J., Munzenrider J.E., et al. Advanced prostate cancer: The results of a randomized comparative trial of high dose irradiation boosting with conformal protons compared with conventional dose irradiation using photons alone. Int J Radiat Oncol Biol Phys 32 (1995) 3-12
27. Dearnaley D.P., Sydes M.R., Graham J.D., et al. Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: First results from the MRC RT01 randomised controlled trial. Lancet Oncol 8 (2007) 475-487
28. Beckendorf V., Guerif S., Le Prise E., et al. The GETUG 70 Gy vs. 80 Gy randomized trial for localized prostate cancer: Feasibility and acute toxicity. Int J Radiat Oncol Biol Phys 60 (2004) 1056-1065
29. Kupelian P.A., Buchsbaum J.C., Reddy C.A., et al. Radiation dose response in patients with favorable localized prostate cancer (Stage T1-T2, biopsy Gleason < or = 6, and pretreatment prostate-specific antigen < or = 10). Int J Radiat Oncol Biol Phys 50 (2001) 621-633
30. Nutting C.M., Convery D.J., Cosgrove V.P., et al. Reduction of small and large bowel irradiation using an optimized intensity-modulated pelvic radiotherapy technique in patients with prostate cancer. Int J Radiat Oncol Biol Phys 48 (2000) 649-660
31. Zelefsky M.J., Fuks Z., Hunt M., et al. High-dose intensity modulated radiation therapy for prostate cancer: Early toxicity and biochemical outcome in 772 patients. Int J Radiat Oncol Biol Phys 53 (2002) 1111-1123
32. Zelefsky M.J., Chan H., Hunt M., et al. Long-term outcome of high dose intensity modulated radiation therapy for patients with clinically localized prostate cancer. J Urol 176 (2006) 1415-1428